Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Buy
1,847
+91
+5% +$10.7K 0.1% 133
2026
Q1
$211K Buy
+1,756
New +$203K 0.09% 136
2024
Q3
Sell
-1,811
Closed -$224K 122
2024
Q2
$224K Buy
1,811
+80
+5% +$10.3K 0.13% 90
2024
Q1
$228K Buy
+1,731
New +$213K 0.13% 88
2023
Q3
Sell
-2,056
Closed -$237K 112
2023
Q2
$237K Sell
2,056
-94
-4% -$10.7K 0.13% 82
2023
Q1
$229K Sell
2,150
-8,296
-79% -$896K 0.13% 84
2022
Q4
$1.16M Sell
10,446
-419
-4% -$42.8K 0.67% 34
2022
Q3
$936K Buy
10,865
+567
+6% +$50.6K 0.51% 33
2022
Q2
$939K Buy
10,298
+1,282
+14% +$114K 0.49% 36
2022
Q1
$740K Buy
9,016
+1,016
+13% +$80.1K 0.34% 45
2021
Q4
$613K Buy
8,000
+792
+11% +$63.1K 0.27% 46
2021
Q3
$541K Buy
+7,208
New +$548K 0.26% 43
2020
Q1
Sell
-2,432
Closed -$211K 114
2019
Q4
$211K Buy
+2,432
New +$200K 0.1% 106

Other funds holding MRK

IRON Financial's MRK Position: Q2 2026 in Review

IRON Financial increased its Merck (MRK) stake by 5.2% in Q2 2026, buying an estimated $10.7K and bringing the position to 1,847 shares worth $237K. The position accounts for 0.1% of the portfolio, ranked #133.

IRON Financial first reported a position in MRK in Q4 2019 and has held it in 13 quarters since. The position peaked at $1.16M in Q4 2022. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • IRON Financial held 1,847 shares of Merck worth $237K as of Q2 2026.
  • IRON Financial bought 91 Merck shares in Q2 2026, an estimated $10.7K.
  • Merck made up 0.1% of IRON Financial's portfolio in Q2 2026, its #133 holding.
  • IRON Financial first reported a position in Merck in Q4 2019 and has held it in 13 quarters since.
  • IRON Financial's Merck position peaked at $1.16M in Q4 2022.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on IRON Financial's 13F filing for Q2 2026, filed 22 Jul 2026.